Abstract
Background/aim: The relationship between the kinetics of antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the severity of Coronavirus Disease 2019 (COVID-19) is poorly understood. The aim of the present study was to investigate whether serum SARS-CoV-2 antibody kinetics serve as an early predictor of clinical deterioration or recovery in hospitalized patients with COVID-19.
Patients and methods: In this prospective observational study, 102 consecutive patients (median age: 60 years, 58% males) with symptomatic COVID-19 infection diagnosed by real-time polymerase chain reaction assay, hospitalized in two tertiary hospitals, were included. Rapid test for qualitative detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) SARS-CoV-2 antibodies was performed at pre-defined time intervals during hospitalization (days: 0, 3, 7, 10, 14, 21 and 28).
Results: During a 3-month follow-up period after COVID-19 disease onset, a total of 87 patients were discharged, 12 patients were intubated and entered the Intensive Care Unit, and three patients died. The median time for seroconversion was 10 days for IgM and 12 days for IgG post onset of symptoms. Univariate logistic regression analysis found no associations between IgM or IgG positivity and clinical outcomes or complications during hospitalization for COVID-19 infection. Diabetes and dyslipidemia were the only clinical risk factors predictive of COVID-19-related complications during hospitalization.
Conclusion: SARS-CoV-2 antibody responses do not predict clinical outcome in hospitalized patients with moderate-to-severe COVID-19 infection.
Keywords: Coronavirus Disease 2019; Severe acute respiratory syndrome coronavirus 2; antibody kinetics; seroconversion.
【저자키워드】 severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, antibody kinetics, seroconversion., 【초록키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, IgG, IgM, Coronavirus disease 2019, coronavirus, Hospitalized, Hospitalization, antibody, prospective observational study, severity, Antibody Response, Infection, intensive care unit, diabetes, hospitalized patients, severe acute respiratory syndrome Coronavirus, observational study, clinical outcomes, hospitals, COVID-19 disease, Clinical outcome, polymerase chain reaction, serum, Kinetics, Antibody responses, Immunoglobulin G, Seroconversion, SARS-CoV-2 antibody, Rapid test, Immunoglobulin, COVID-19 infection, symptomatic, antibody kinetics, response, Patient, Rapid, Complication, respiratory, predict, dyslipidemia, association, Clinical deterioration, immunoglobulin M, Predictive, Chain Reaction, time interval, time intervals, acute respiratory syndrome, Logistic regression analysis, Intubated, follow-up period, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, Univariate logistic regression analysis, moderate-to-severe COVID-19, median time, median age, IgG positivity, COVID-19-related complications, qualitative detection, males, polymerase chain, diagnosed, was performed, median, hospitalized patient, onset of symptoms, discharged, clinical risk factor, consecutive patient, COVID-19-related complication, patients died, with COVID-19, 【제목키워드】 clinical, response,